BGB-43395-302
Not yet recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
BeOne Study ID
BGB-43395-302
ClinicalTrials.gov ID
EudraCT or EUCT Number
2025-523960-19-00
Study Overview
Sex: All
Age: 18 Years / N/A
Accepts Healthy Volunteers? No
No Study Documents
Locations
Study Overview
Sex: All
Age: 18 Years / N/A
Accepts Healthy Volunteers? No
No Study Documents